---
title: "The synthetic biology concept strengthens, ALK hits the limit up"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248883678.md"
description: "The synthetic biology concept is gaining strength. As of 10:16 AM, ZHEJIANG ZHENYUAN and ALK have reached the daily limit, Boji Pharmaceutical has risen over 10%, and Biological Shares, Kexing Pharmaceutical, and Hongbo Pharmaceutical have all increased by over 5%"
datetime: "2025-07-17T02:20:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248883678.md)
  - [en](https://longbridge.com/en/news/248883678.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248883678.md)
generator: "portal-rs"
---

# The synthetic biology concept strengthens, ALK hits the limit up

The synthetic biology concept is gaining strength. As of 10:16, ZHEJIANG ZHENYUAN and ALK have reached the daily limit, Boji Pharmaceutical has risen over 10%, and Biological Products, Sinovac Biotech, and Hongbo Pharmaceutical have all increased by over 5%

### Related Stocks

- [002940.CN](https://longbridge.com/en/quote/002940.CN.md)
- [000705.CN](https://longbridge.com/en/quote/000705.CN.md)

## Related News & Research

- [Lens Technology Half-Year Profit Halves as Revenue Slides, Dividend Maintained](https://longbridge.com/en/news/296653059.md)
- [Fibocom sells Shanghai Faiot industrial handheld unit to Luxshare for RMB 120 million](https://longbridge.com/en/news/296613884.md)
- [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md)
- [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md)
- [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**